Tim Mayleben sold $1.58M worth of shares in Loxo Oncology, Inc. in June 2018

Jul 08, 2018
Insider Transactions
Background Information
Loxo Oncology, Inc. is a biopharmaceutical company, which engages in the development of small molecule therapeutics for the treatment of cancer. It focuses on genetic alterations, targeted therapies, and genetic testing. The company was founded by Joshua H. Bilenker in May 2013 and is headquartered in Stamford, CT.